Sorry, this section is only available in Japanese.
著者 (37件)：
資料名：
巻： 22 号： 9 ページ： 1064-1075 発行年： 2020年
JST資料番号： W1369A ISSN： 1465-7392 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： ドイツ (DEU) 言語： 英語 (EN)
前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202002289866978224
整理番号：20A2034314
PD-L1核転座のアセチル化依存性調節は抗PD-1免疫療法の有効性を決定する【JST・京大機械翻訳】
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Gao Yang
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Gao Yang
(Department of Urology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China)
,
Nihira Naoe Taira
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Nihira Naoe Taira
(Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan)
,
Nihira Naoe Taira
(Division of Pediatric Dentistry, Department of Oral Health and Development Sciences, Tohoku University Graduate School of Dentistry, Sendai, Japan)
,
Bu Xia
(Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA)
,
Chu Chen
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Chu Chen
(Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA)
,
Zhang Jinfang
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Kolodziejczyk Aleksandra
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Kolodziejczyk Aleksandra
(Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA)
,
Fan Yizeng
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Fan Yizeng
(Department of Urology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China)
,
Chan Ngai Ting
(McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA)
,
Ma Leina
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Liu Jing
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Wang Dong
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Dai Xiaoming
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Liu Huadong
(Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology and Frontier Institute of Science and Technology, Xi’an Jiaotong University, Xi’ an, China)
,
Ono Masaya
(Department of Clinical Proteomics, National Cancer Center Research Institute, Tokyo, Japan)
,
Nakanishi Akira
(Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan)
,
Inuzuka Hiroyuki
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
North Brian J.
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
,
Huang Yu-Han
(Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA)
,
Huang Yu-Han
(Division of Genetics and Genomics, Boston Children’s Hospital, Boston, MA, USA)
,
Sharma Samanta
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Sharma Samanta
(Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA)
,
Geng Yan
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Geng Yan
(Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA)
,
Xu Wei
(McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA)
,
Liu X. Shirley
(Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Li Lei
(Department of Urology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China)
,
Miki Yoshio
(Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan)
,
Sicinski Piotr
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Sicinski Piotr
(Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA)
,
Freeman Gordon J.
(Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA)
,
Wei Wenyi
(Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
資料名：
Nature Cell Biology
(Nature Cell Biology)
巻： 22 号： 9 ページ： 1064-1075 発行年： 2020年
JST資料番号： W1369A ISSN： 1465-7392 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： ドイツ (DEU) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。